SCHEMBL25823310

SCHEMBL25823310

C=CC(=O)OCCOC(=O)CCC(=O)OCCNC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.48
ALDH1A1 P00352 4/20 0.48
TP53 P04637 3/20 0.48
HIF1A Q16665 3/20 0.48
HSD17B10 Q99714 1/20 0.48
THRB P10828 2/20 0.45
CYP3A4 P08684 2/20 0.44
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA1A P35348 1/20 0.32
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
DGKA P23743 1/20 0.31
KDM4E B2RXH2 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910467 0.89 TSHR (0.54) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL25822496 0.84 TSHR (0.46) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL303596 0.84 TSHR (0.67) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL17119709 0.84 TSHR (0.67) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL16425946 0.81 TSHR (0.50) TSHRALDH1A1TP53HIF1AHSD17B10
Succinic Acid SCHEMBL30527931 0.80 TSHR (0.57) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL25823302 0.80 TSHR (0.57) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL33640 0.80 TSHR (0.57) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL26622823 0.80 TSHR (0.57) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL23225387 0.79 SMN1; SMN2 (0.41) TSHRALDH1A1TP53HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT TERB1, RER1, LARP1 TSHR 3138/4885ALDH1A1 228/4885TP53 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.